Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 31,013 shares at $9.98 ($305K) on 2017-05-18, disclosed to the SEC on 2017-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.98 | 11,013 | $110K | 36.0% |
| 2 | $9.83 | 3,100 | $30K | 10.0% |
| 3 | $9.76 | 16,900 | $165K | 54.0% |
| Total | $9.85 avg | 31,013 | $305K | 100% |
| Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |
| ANF | BUY | 2016-09-06 | $177K | — | Filing → |
| FLML | BUY | 2016-09-06 | $135K | — | Filing → |